Text size [+][-] Tuesday February 9 2010GLOBAL EDITION
Home > Deal payments
By Robert Cyran
Pfizer has awarded its chief financial officer, Frank D’Amelio, a $1.2m extraordinary award for his role in the drug company’s acquisition of rival Wyeth. One half consists of cash. The remainder consists of restricted stock and total shareholder return units, both of which vest over three years. Separately, the chief executive of Black & Decker, Nolan Archibald, agreed to sell the firm to rival Stanley Works. Archibald waived his right to an immediate vesting of his restricted stock and options, a payment of three times his annual salary and a tax gross up worth more than $20m in total. He will become executive chairman at the combined firm.
robert.cyran@breakingviews.com